Intra-Cellular Therapies, Inc.: 10-Q filed 2018-08-02

Name: Intra-Cellular Therapies, Inc.: 10-Q filed 2018-08-02
Creator: Intra-Cellular Therapies, Inc.

What Intra-Cellular Therapies, Inc. reported in its quarterly report filed 2018-08-02 (fiscal Q2 2018): 34 published measures, 87 facts as tagged in accession 0001193125-18-236597.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-08-02
Fiscal period: fiscal Q2 2018
Accession: 0001193125-18-236597 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Intra-Cellular Therapies, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-06-30	412,073,723	USD
At 2017-12-31	471,486,699	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-06-30	21,686,281	USD
At 2017-12-31	17,049,738	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-06-30	390,387,442	USD
At 2017-12-31	454,436,961	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2018-06-30	69,767,045	USD
At 2017-12-31	37,790,114	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-37,376,383	USD	91
2018-01-01 to 2018-06-30	-72,856,461	USD	181
2017-04-01 to 2017-06-30	-17,760,704	USD	91
2017-01-01 to 2017-06-30	-44,694,286	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	-60,598,040	USD	181
2017-01-01 to 2017-06-30	-41,286,851	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	316,492	USD	181
2017-01-01 to 2017-06-30	103,088	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	114,741	USD	91
2017-01-01 to 2017-06-30	210,028	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	343,926	USD	181
2017-01-01 to 2017-06-30	230,784	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	92,231,045	USD	181
2017-01-01 to 2017-06-30	22,004,288	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-06-30	-480,105,241	USD
At 2017-12-31	-407,248,780	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	1,600	USD	91
2018-01-01 to 2018-06-30	1,600	USD	181
2017-04-01 to 2017-06-30	0	USD	91
2017-01-01 to 2017-06-30	1,600	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-06-30	1,275,387	USD
At 2017-12-31	1,137,171	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	4,310,705	USD	91
2018-01-01 to 2018-06-30	8,597,808	USD	181
2017-04-01 to 2017-06-30	4,369,141	USD	91
2017-01-01 to 2017-06-30	8,529,819	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-39,168,257	USD	91
2018-01-01 to 2018-06-30	-76,252,483	USD	181
2017-04-01 to 2017-06-30	-18,618,513	USD	91
2017-01-01 to 2017-06-30	-46,372,670	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-06-30	409,661,068	USD
At 2017-12-31	469,215,328	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-06-30	18,935,367	USD
At 2017-12-31	14,209,606	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-06-30	5,378,870	USD
At 2017-12-31	6,173,539	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	39,168,257	USD	91
2018-01-01 to 2018-06-30	76,252,483	USD	181
2017-04-01 to 2017-06-30	18,733,254	USD	91
2017-01-01 to 2017-06-30	46,582,698	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	32,439,270	USD	91
2018-01-01 to 2018-06-30	63,142,268	USD	181
2017-04-01 to 2017-06-30	12,478,638	USD	91
2017-01-01 to 2017-06-30	34,017,596	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-06-30	54,700,580	shares
At 2017-12-31	54,597,679	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2018-06-30	69,767,045	USD
At 2017-12-31	37,790,114	USD
At 2017-06-30	29,590,446	USD
At 2016-12-31	48,642,225	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2018-06-30	-1,029,424	USD
At 2017-12-31	-799,224	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2018-06-30	4,122,222	USD
At 2017-12-31	3,829,959	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2018-06-30	2,846,835	USD
At 2017-12-31	2,692,788	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-06-30	78,833	USD
At 2017-12-31	75,765	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-06-30	5,896,583	USD
At 2017-12-31	4,884,293	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-37,374,783	USD	91
2018-01-01 to 2018-06-30	-72,854,861	USD	181
2017-04-01 to 2017-06-30	-17,760,704	USD	91
2017-01-01 to 2017-06-30	-44,692,686	USD	181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	-72,856,461	USD	181
2017-01-01 to 2017-06-30	-44,694,286	USD	181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	-37,166,057	USD	91
2018-01-01 to 2018-06-30	-73,086,661	USD	181
2017-04-01 to 2017-06-30	-17,784,823	USD	91
2017-01-01 to 2017-06-30	-44,692,874	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-04-01 to 2018-06-30	6,728,987	USD	91
2018-01-01 to 2018-06-30	13,110,215	USD	181
2017-04-01 to 2017-06-30	6,254,616	USD	91
2017-01-01 to 2017-06-30	12,565,102	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	178,276	USD	181
2017-01-01 to 2017-06-30	101,801	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-32,404	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	-794,669	USD	181
2017-01-01 to 2017-06-30	-1,979,395	USD	181

Inspect the source

Entity: Intra-Cellular Therapies, Inc. / CIK 0001567514
Captured: 2026-09-21T17:20:04.465Z
SEC response SHA-256: d515a2828c30b442b80d2f88dbecd3b8d47803a78a686cc6f7c16f5ab9f2019e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001567514.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))